Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | %Female (1999) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Inhalation Toxicology | journal | 0.426 Q3 | 97 | 69 | 173 | 2281 | 189 | 172 | 0.90 | 33.06 | 26.42 | |
52 | Chemical Speciation and Bioavailability | journal | 0.421 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
53 | ATLA Alternatives to Laboratory Animals | journal | 0.413 Q3 | 65 | 76 | 150 | 2170 | 187 | 144 | 1.08 | 28.55 | 39.34 | |
54 | Biopharmaceutics and Drug Disposition | journal | 0.408 Q2 | 65 | 61 | 212 | 1339 | 225 | 208 | 1.05 | 21.95 | 24.36 | |
55 | Journal of Applied Toxicology | journal | 0.401 Q3 | 103 | 79 | 205 | 2204 | 225 | 205 | 1.24 | 27.90 | 27.62 | |
56 | Phytotherapy Research | journal | 0.397 Q2 | 158 | 160 | 625 | 2854 | 270 | 622 | 0.36 | 17.84 | 36.59 | |
57 | Fundamental and Clinical Pharmacology | journal | 0.394 Q2 | 85 | 69 | 290 | 2303 | 284 | 288 | 0.84 | 33.38 | 25.75 | |
58 | Drug Design and Discovery | journal | 0.384 Q3 | 20 | 21 | 57 | 607 | 51 | 56 | 0.81 | 28.90 | 16.44 | |
59 | Toxicology in Vitro | journal | 0.382 Q3 | 125 | 109 | 261 | 2529 | 288 | 259 | 1.08 | 23.20 | 40.73 | |
60 | Toxicology and Industrial Health | journal | 0.376 Q3 | 69 | 73 | 158 | 4477 | 177 | 157 | 1.20 | 61.33 | 29.41 | |
61 | Mathematical Medicine and Biology | journal | 0.368 Q2 | 49 | 18 | 59 | 531 | 45 | 59 | 0.88 | 29.50 | 16.67 | |
62 | International Journal of Geriatric Psychopharmacology | journal | 0.365 Q1 | 11 | 11 | 53 | 297 | 65 | 50 | 1.23 | 27.00 | 42.11 | |
63 | Journal of Pharmacy and Pharmacology | journal | 0.365 Q2 | 137 | 632 | 1384 | 8341 | 1055 | 1353 | 0.70 | 13.20 | 26.77 | |
64 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.360 Q3 | 54 | 454 | 355 | 4222 | 298 | 353 | 0.81 | 9.30 | 20.41 | |
65 | Expert Opinion on Therapeutic Patents | journal | 0.356 Q2 | 88 | 143 | 398 | 6018 | 323 | 394 | 1.02 | 42.08 | 17.65 | |
66 | Expert Opinion on Investigational Drugs | journal | 0.348 Q2 | 117 | 155 | 426 | 12075 | 435 | 418 | 1.06 | 77.90 | 19.49 | |
67 | Immunopharmacology and Immunotoxicology | journal | 0.343 Q2 | 61 | 51 | 115 | 1749 | 103 | 115 | 0.81 | 34.29 | 24.38 | |
68 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.343 Q2 | 92 | 33 | 119 | 1167 | 129 | 119 | 1.42 | 35.36 | 32.28 | |
69 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.340 Q2 | 57 | 32 | 114 | 1171 | 61 | 106 | 0.58 | 36.59 | 12.50 | |
70 | International Journal of Cosmetic Science | journal | 0.334 Q2 | 77 | 37 | 80 | 642 | 56 | 80 | 0.64 | 17.35 | 40.79 | |
71 | Toxicological Sciences | journal | 0.332 Q3 | 207 | 212 | 482 | 8424 | 871 | 477 | 1.57 | 39.74 | 29.43 | |
72 | Journal of Liposome Research | journal | 0.331 Q2 | 64 | 41 | 122 | 1331 | 108 | 115 | 0.79 | 32.46 | 27.59 | |
73 | International Journal of Neuropsychopharmacology | journal | 0.324 Q2 | 125 | 40 | 26 | 1850 | 20 | 26 | 0.77 | 46.25 | 20.83 | |
74 | SAR and QSAR in Environmental Research | journal | 0.315 Q3 | 54 | 18 | 42 | 292 | 44 | 42 | 0.86 | 16.22 | 15.56 | |
75 | Drug Delivery | journal | 0.314 Q2 | 95 | 31 | 110 | 866 | 76 | 110 | 0.64 | 27.94 | 24.10 | |
76 | Pharmaceutical Journal | journal | 0.310 Q2 | 28 | 439 | 957 | 1954 | 158 | 516 | 0.15 | 4.45 | 48.28 | |
77 | Journal of Drug Development and Clinical Practice | journal | 0.309 Q2 | 9 | 0 | 39 | 0 | 37 | 35 | 0.00 | 0.00 | 0.00 | |
78 | Journal of Chemotherapy | journal | 0.307 Q2 | 56 | 103 | 284 | 2600 | 250 | 276 | 0.82 | 25.24 | 29.07 | |
79 | Archives Internationales de Pharmacodynamie et de Therapie | journal | 0.303 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
80 | Antiviral Therapy | journal | 0.300 Q3 | 93 | 55 | 177 | 390 | 99 | 159 | 0.54 | 7.09 | 35.00 | |
81 | Pharmacy and Pharmacology Communications | journal | 0.273 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
82 | ChemMedChem | journal | 0.269 Q2 | 119 | 124 | 352 | 3203 | 201 | 351 | 0.46 | 25.83 | 43.13 | |
83 | Expert Opinion on Emerging Drugs | journal | 0.264 Q3 | 54 | 20 | 43 | 1380 | 34 | 42 | 0.79 | 69.00 | 12.50 | |
84 | International Antiviral News | journal | 0.264 Q3 | 8 | 27 | 109 | 367 | 45 | 84 | 0.39 | 13.59 | 33.33 | |
85 | Pharmaceutical Sciences | journal | 0.259 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
86 | Pharmacology Communications | journal | 0.251 Q3 | 8 | 0 | 119 | 0 | 50 | 119 | 0.36 | 0.00 | 0.00 | |
87 | Toxicology Methods | journal | 0.248 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
88 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.242 Q3 | 81 | 63 | 184 | 2007 | 98 | 171 | 0.37 | 31.86 | 29.25 | |
89 | Reviews in Contemporary Pharmacotherapy | journal | 0.238 Q3 | 18 | 15 | 109 | 256 | 66 | 109 | 0.73 | 17.07 | 5.56 | |
90 | Comments on Toxicology | journal | 0.237 Q3 | 13 | 25 | 53 | 400 | 26 | 44 | 0.21 | 16.00 | 30.77 | |
91 | IDrugs : the investigational drugs journal | journal | 0.237 Q3 | 39 | 183 | 58 | 7804 | 20 | 58 | 0.34 | 42.64 | 20.69 | |
92 | BioDrugs | journal | 0.226 Q3 | 79 | 79 | 272 | 5247 | 182 | 257 | 0.65 | 66.42 | 25.88 | |
93 | Acta Pharmacologica Sinica | journal | 0.225 Q3 | 117 | 220 | 446 | 3264 | 197 | 446 | 0.48 | 14.84 | 32.30 | |
94 | Pharmaceutical Biology | journal | 0.222 Q2 | 88 | 85 | 344 | 1674 | 78 | 341 | 0.18 | 19.69 | 37.67 | |
95 | Toxic Substance Mechanisms | journal | 0.218 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
96 | Toxin Reviews | journal | 0.205 Q4 | 54 | 24 | 93 | 1269 | 57 | 88 | 0.60 | 52.88 | 27.59 | |
97 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.197 Q3 | 25 | 15 | 51 | 919 | 35 | 40 | 0.79 | 61.27 | 25.00 | |
98 | Journal of Applied Therapeutic Research | journal | 0.184 Q3 | 8 | 20 | 23 | 359 | 5 | 23 | 0.22 | 17.95 | 15.00 | |
99 | Journal of Pharmaceutical Medicine | journal | 0.167 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
100 | Pharmacology Reviews and Communications | journal | 0.158 Q3 | 9 | 22 | 102 | 559 | 32 | 102 | 0.43 | 25.41 | 30.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®